185 related articles for article (PubMed ID: 10935255)
21. The pathologic substrate of magnetic resonance alterations in multiple sclerosis.
Lassmann H
Neuroimaging Clin N Am; 2008 Nov; 18(4):563-76, ix. PubMed ID: 19068402
[TBL] [Abstract][Full Text] [Related]
22. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
[TBL] [Abstract][Full Text] [Related]
23. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
Oh J; Pelletier D; Nelson SJ
Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
[TBL] [Abstract][Full Text] [Related]
24. Gray matter involvement in multiple sclerosis.
Pirko I; Lucchinetti CF; Sriram S; Bakshi R
Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
[TBL] [Abstract][Full Text] [Related]
25. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
Andrews HE; Nichols PP; Bates D; Turnbull DM
Med Hypotheses; 2005; 64(4):669-77. PubMed ID: 15694681
[TBL] [Abstract][Full Text] [Related]
27. A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes.
Zipp F
J Neurol Sci; 2009 Dec; 287 Suppl 1():S24-9. PubMed ID: 20106345
[TBL] [Abstract][Full Text] [Related]
28. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
Ranjeva JP; Audoin B; Pelletier J; Confavreux C
Rev Prat; 2006 Jun; 56(12):1326-35. PubMed ID: 16948221
[TBL] [Abstract][Full Text] [Related]
29. T1 hypointensities and axonal loss.
Barkhof F; Karas GB; van Walderveen MA
Neuroimaging Clin N Am; 2000 Nov; 10(4):739-52 ,ix. PubMed ID: 11359722
[TBL] [Abstract][Full Text] [Related]
30. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
[TBL] [Abstract][Full Text] [Related]
31. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.
De Stefano N; Narayanan S; Matthews PM; Mortilla M; Dotti MT; Federico A; Arnold DL
J Neurovirol; 2000 May; 6 Suppl 2():S121-9. PubMed ID: 10871799
[TBL] [Abstract][Full Text] [Related]
32. Biological indicators of the neurodegenerative phase of multiple sclerosis.
Zaffaroni M
Neurol Sci; 2003 Dec; 24 Suppl 5():S279-82. PubMed ID: 14652789
[TBL] [Abstract][Full Text] [Related]
33. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
34. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis.
Brochet B; Dousset V
Neurology; 1999; 53(5 Suppl 3):S12-7. PubMed ID: 10496205
[TBL] [Abstract][Full Text] [Related]
35. [Magnetic resonance spectroscopy in multiple sclerosis].
Viala K; Stievenart JL; Cabanis EA; Lyon-Caen O; Tourbah A
Rev Neurol (Paris); 2000 Dec; 156(12):1078-86. PubMed ID: 11139723
[TBL] [Abstract][Full Text] [Related]
36. [Axonal degeneration in the pathogenesis of multiple sclerosis].
Mirowska D; Członkowska A
Neurol Neurochir Pol; 2002; 36(4):777-89. PubMed ID: 12418141
[TBL] [Abstract][Full Text] [Related]
37. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis.
De Stefano N; Bartolozzi ML; Guidi L; Stromillo ML; Federico A
J Neurol Sci; 2005 Jun; 233(1-2):203-8. PubMed ID: 15949506
[TBL] [Abstract][Full Text] [Related]
39. Inflammation and degeneration in multiple sclerosis.
Brück W; Stadelmann C
Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
[TBL] [Abstract][Full Text] [Related]
40. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
Mathiesen HK; Langkilde AR; Larsson HB
Ugeskr Laeger; 2002 Feb; 164(8):1031-6. PubMed ID: 11894703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
